Norris Medicines Ltd

Norris Medicines Board Meeting Date

Norris Medicines Limited intimated a prior board meeting on 14 Nov 2026 to consider unaudited standalone quarterly results for September 2026. Trading window closed from 01 Oct to 16 Nov 2026.

Norris Medicines Other Announcement

Norris Medicines Ltd submitted its quarterly shareholding pattern for the period ended September 30, 2026, as required by SEBI regulations.

Norris Medicines Annual General Meeting

Norris Medicines Limited held its 35th Annual General Meeting on September 29, 2026, where members transacted various ordinary and special business items.

Norris Medicines Annual Report

Norris Medicines Limited has filed its 35th Annual Report for the financial year 2025-26, including the notice of its upcoming Annual General Meeting.

Norris Medicines Annual General Meeting

Norris Medicines approved the Directors' Report, Annual Report, and convening of the 35th Annual General Meeting for September 29, 2026.

Norris Medicines Q1 FY27 Results: Net Loss of ₹0.4 Cr, Loss Widens

Norris Medicines Ltd reported revenue from operations of ₹0.9 Cr (-40.0% YoY) and a net loss of ₹0.4 Cr for Q1 FY27.

Key figure

Net loss ₹0.4 Cr